The Street’s Key Stock Analysts Research Reports

$ABT, $BSX, $DVA, $MDT, $SWKS, $ALL, $AZPN, $BAX, $CPK,$HRC

Investors will not receive any notable economic data for the rest of the week.

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Thursday as follows:

Abbott Laboratories (NYSE:ABT) was started with a Buy rating and assigned an 83 price target at UBS in a broader healthcare initiation. The consensus target price is 78.94.

Boston Scientific Corp. (NYSE:BSX) was started with a Buy rating and assigned a 45 target price at UBS. It has a 52-wk trading range of 24.54 – 39.44 and a consensus price target at 42.29.

DaVita Inc. (NYSE:DVA) analysts raised DVA to Outperform from Market Perform with a 70 price target at Raymond James.

Medtronic PLC (NYSE:MDT) was started with a Buy rating and assigned a$112 price target at UBS. The consensus target is at 104, and the 52-wk trading range is 76.41 – 100.15.

Skyworks Solutions Inc. (NASDAQ:SWKS) was raised to Equal Weight from Underweight and analysts held its target price at 76 at Morgan Stanley.

Allstate Corp. (NYSE:ALL) was maintained as Buy at Argus, but the firm lowered its target price to 106 from 115 following its Q-3 results. The 52-wk trading range is 86.77 – 105.36, and the consensus price target is at 107.40.

Aspen Technology Inc. (NASDAQ:AZPN) was raised to Buy from Hold and its price target was maintained at 100 at Canaccord Genuity. The 52-wk trading range is 65.03 – 118.86, and the consensus price target is at 105.17.

Baxter International Inc. (NYSE:BAX) was started with a Buy rating and assigned an 80 price target at UBS.

Chesapeake Utilities Corp. (NYSE:CPK) was started with a Buy rating and assigned a 100 target price at Maxim Group.

Hill-Rom Holdings Inc. (NYSE:HRC) was started with a Buy rating and assigned a 115 price target at UBS.

Stay tuned…

  ABT, ALL, analysts, AZPN, BAX, BSX, buy, CPK, DVA, heffx, HRC, market, MDT, outlook, report, research, sell, street, swks, Wall

The following two tabs change content below.

• Bio
• Latest Posts

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

• Indonesia’s Chocolate Dream is Sustainable Cocoa Farming - April 21, 2019
• Ferrari’s (NYSE:RACE) ‘Seb’ Vettel is F1’s Largest Prize Money Winner With $510-M+ Take So Far - April 20, 2019
• Corporate Earning Beating Expectations Again This Season - April 20, 2019